Transhiatal esophagectomy for carcinoma of the esophagus

doi:10.1016/0003-4975(93)90341-E

The Annals of Thoracic Surgery

Volume 56, Issue 4, October 1993, Pages 838-846

https://doi.org/10.1016/0003-4975(93)90341-E Get rights and content

Abstract

One hundred thirty-one patients (107 men and 24 women) underwent transhiatal esophagectomy for carcinoma of the esophagus. Median age was 65.3 years (range, 30 to 89 years). Signs and symptoms were present in 130 patients, which included dysphagia in 96 (73.3%) and weight loss (median, 7.7 kg) in 52 (39.7%). The cancer involved the gastroesophageal junction in 94 patients, the lower half of the intrathoracic esophagus in 25, the upper half in 10, and multiple sites in 2. An adenocarcinoma was present in 101 patients (77.1%), squamous cell carcinoma in 29 (22.1%), and adenosquamous cell in 1 (0.8%). The cancer was classified as stage 0 in 4 patients, stage I in 16, stage IIA in 26, stage IIB in 18, stage III in 65, and stage IV in 1. The stomach was used to replace the esophagus in all patients. Operative mortality was 2.3%. Anastomotic leak developed in 32 patients; 6 leaks were not clinically significant, 12 healed with drainage alone, and 14 required further surgical intervention. Follow-up ranged from 1 month to 6.7 years (median, 1.4 years). Currently, 42 patients are alive, 34 without evidence of recurrence. Overall 5-year survival was 20.8% and varied according to stage. Five-year survival was 47.5% for patients with stage I disease compared with 37.7% for patients in stage II and only 5.8% 4-year survival for patients in stage III. Cell type also influenced survival. Five-year survival for patients with adenocarcinoma was 27.1% compared with zero for patients with squamous cell carcinoma (p < 0.03). Forty patients (33.9%) had development of late dysphagia (23 malignant, 17 benign) and 33 required dilation. We conclude that transhiatal esophagectomy for cancer of the esophagus can be performed with low operative mortality, satisfactory long-term survival, and good long-term function, but that associated morbidity is substantial.

References (28)

MB Orringer
Transhiatal esophagectomy for benign disease
J Thorac Cardiovasc Surg
(1985)
RM King et al.
Ivor Lewis esophagogastrectomy for carcinoma of the esophagus: early and late functional results
Ann Thorac Surg
(1987)
DJ Mathisen et al.
Transthoracic esophagectomy: a safe approach to carcinoma of the esophagus
Ann Thorac Surg
(1988)
MB Orringer
Transthoracic versus transhiatal esophagectomy: what difference does it make?
Ann Thorac Surg
(1987)
DM Shahian et al.
Transthoracic versus extrathoracic esophagectomy: mortality, morbidity, and long-term survival
Ann Thorac Surg
(1986)
MB Orringer et al.
Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma
Ann Thorac Surg
(1990)
DB Skinner
En bloc resection for neoplasms of the esophagus and cardia
J Thorac Cardiovasc Surg
(1983)
MB Orringer et al.
Transhiatal esophagectomy for benign and malignant disease of the intrathoracic esophagus
J Thorac Cardiovasc Surg
(1993)
JR Hankins et al.
Carcinoma of the esophagus: a comparison of the results of transhiatal versus transthoracic resection
Ann Thorac Surg
(1989)
JL Chassin
Stapling technique for esophagogastrostomy after esophagogastric resection
Am J Surg
(1978)

DMI Liebermann-Meffert et al.

Vascular anatomy of the gastric tube used for esophageal reconstruction

Ann Thorac Surg

(1992)

MB Orringer et al.

Substernal gastric bypass of the excluded thoracic esophagus for palliation of esophageal carcinoma

J Thorac Cardiovasc Surg

(1975)

MB Orringer

Technical aids in performing transhiatal esophagectomy without thoracotomy

Ann Thorac Surg

(1984)

M Fok et al.

A comparison of transhiatal and transthoracic resection for carcinoma of the thoracic esophagus

Am J Surg

(1989)

Cited by (126)

Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer
2017, Annals of Thoracic Surgery
The impact of sex on the outcomes of treatment for locally advanced esophageal carcinoma is unclear. This study analyzed the impact of sex on response to neoadjuvant chemoradiotherapy (nCRT), tumor recurrence, and survival.
From January 1990 through December 2013, female patients who received nCRT followed by esophagogastrectomy at 3 affiliated centers were compared with control male patients based on age, pretreatment clinical stage, histologic type, and surgical era. Only patients staged preoperatively with computed tomographic scans and endoscopic ultrasonography (EUS) were included.
There were 366 patients (145 women and 221 men). The median female age was 64 years (range, 22–81 years), whereas male patients were 61 years (range, 33–82 years). The histologic type was adenocarcinoma in 105 (72%) women and 192 (87%) men, and it was squamous cell carcinoma in 40 (28%) women and 29 (13%) men (p = 0.005). Women were more likely to attain either a complete pathologic (CP) response or a nearly complete pathologic (NCP) response to induction therapy (84 [58%]) compared with men (103 [47%]; p = 0.034). Men had an 80% increased risk of recurrence (hazard ratio [HR], 1.80; 95% CI, 1.15–2.68; p = 0.008). There was no sex association with risk of death (p = 0.538). Irrespective of sex, a partial responder (relative to a complete or nearly complete responder) was 3 times more likely to have recurrence (HR, 2.96; 95% CI, 1.98–4.43; p < 0.001) and 2.5 times more likely to die (HR, 2.56; 95% CI, 1.88-3.48; p < 0.001).
Female sex correlated with improved rates of achieving either a CP response or an NCP response after neoadjuvant chemotherapy and a smaller likelihood of experiencing tumor recurrence. Future efforts should be directed at understanding determinants of this sex disparity.
Embedded three-layer esophagogastric anastomosis reduces morbidity and improves short-term outcomes after esophagectomy for cancer
2016, Annals of Thoracic Surgery
There exists great controversy regarding the use of esophagogastric anastomotic techniques in the treatment of esophageal cancer. The aim of this study was to compare two types of cervical esophagogastric anastomoses with respect to the reduction of postoperative anastomotic leaks, stenosis, and gastroesophageal reflux.
From June 2010 to September 2013, 339 patients who underwent two different cervical esophagogastric anastomotic procedures after thoracolaparoscopic esophagectomy for esophageal cancer were identified.
A total of 166 patients with esophageal cancer were treated using an embedded three-layer anastomosis (embedded group), and 173 were treated using a conventional two-layer anastomosis (conventional group). The rates of anastomotic leak (2.4% [4 of 166] versus 7.5% [13 of 173], p = 0.031) and benign anastomotic stricture (4.8% [8 of 166] versus 12.7% [22 of 173], p = 0.010) were significantly lower in the embedded group compared with the conventional group. The mean reflux scores were significantly higher among the patients in the conventional group compared with the patients in the embedded group at 1 month (25.2 versus 19.0, p = 0.001), 3 months (27.8 versus 21.4, p = 0.001), and 6 months (23.4 versus 17.8, p < 0.001) of follow-up. The mean scores for dysphagia were significantly lower among the patients in the embedded group compared with the patients in the conventional group at both 3 months (22.7 versus 29.8, p = 0.012) and 6 months (16.0 versus 21.3, p = 0.008) of follow-up.
The new embedded three-layer esophagogastric anastomosis offers several advantages and reduces the incidence of postoperative complications such as anastomotic leak, stricture, and gastroesophageal reflux.
Anastomotic Leakage Following Esophagectomy
2015, Thoracic Surgery Clinics
A comprehensive review of anastomotic technique in 432 esophagectomies
2013, Annals of Thoracic Surgery
Little consensus exists and varying outcomes are reported when the 4 most common esophagogastric anastomotic techniques are compared: circular stapled (CS), hand sewn (HS), linear stapled (LS) (longitudinally stapled anastomosis), and modified Collard (MC) (combined linear and transverse stapled anastomosis). This report analyzes outcomes of these anastomotic techniques.
From July 2004 through December 2008, all intrathoracic and cervical esophagogastric anastomoses at our institution were reviewed.
There were 432 patients (358 men, 74 women) who underwent primary esophagogastric operations. Median age was 64 years (range, 23–90 years). The approach was an Ivor Lewis esophagectomy in 254 patients (59%), transhiatal esophagectomy in 115 patients (27%), McKeown (3-hole) esophagectomy in 49 (11%) patients, minimally invasive esophagectomy in 9 (2.1%) patients, and thoracoabdominal esophagectomy in 6 (1.4%) patients. There were 268 intrathoracic (62%) and 164 cervical (38%) anastomoses. Anastomotic techniques included LS in 260 (60%) patients MC in 67 (16%) patients, HS in 57 (13%) patients, and CS in 48 (11%) patients. Operative mortality was 3.7%. Anastomotic leak occurred in 50 patients (11%). Grade III or IV leaks occurred in 21 patients (4.9%), including 13 in the chest (4.8%) and 8 in the neck (4.9%). Grade III or IV leaks occurred in 12 patients (4.6%) with LS anastomoses, in 4 (7.0%) patients with HS anastomoses, in 3 (6.2%) patients with CS anastomoses, and in 2 (3.0%) patients with MC anastomoses. HS anastomoses had the highest odds of leakage (p = 0.01) and LS anastomoses had the lowest risk of stricture (p = 0.006).
When performing an esophagogastric anastomosis, clinically significant leaks occur with similar frequency in both cervical and intrathoracic locations. The HS technique has the highest leak rate and the LS technique had the lowest rate of stricture formation.
Esophageal stents for anastomotic leaks and perforations
2011, Journal of Thoracic and Cardiovascular Surgery
Citation Excerpt :
Regardless of the cause and clinical condition of the patient, the principles of management are standardized: resuscitation, broad-spectrum antimicrobial therapy, drainage of contaminated areas, and source control (control or closure of the defect). Despite adherence to these principles and advances in intensive unit care, the morbidity (10%–60%) and mortality (4%–50%) associated with esophageal leaks and perforations are still very high; furthermore, strictures requiring dilations develop in 10% to 50% of patients.1-9 Our report presents the 2 patient populations, with anastomotic leaks and perforations, as one group because the principles of management outlined above are the same for both.
Intrathoracic esophageal anastomotic leaks and perforations are very morbid and challenging problems. Esophageal stents are increasingly playing an integral role in the management of these patients. Our objective was to report our experience with esophageal stent placement for anastomotic leaks and perforations and to provide a treatment algorithm.
We performed a review of patients with stent placement for esophagogastric anastomotic leaks or esophageal perforation from March 2005 to August 2009. A prospective database was used to collect data. Success was defined as endoscopic defect closure, negative esophagram, and resumption of oral intake. Failure was defined as no change in leak size or clinical signs of ongoing infection. We collected and analyzed patient demographics, diagnosis, clinical history, and poststent outcomes using descriptive statistics.
Thirty-seven patients underwent esophageal stent placement for anastomotic leaks (n = 22) and perforations (n = 15). The median time from original procedure to diagnosis of leak or perforation was 6 days (0–420 days). Nineteen patients (51%) had 21 associated procedures for source control. We placed 94 stents (mean = 2.7 stents/patient); 16 patients (43%) required more than 1 stenting procedure (mean = 1.8 procedures/patient). The median time to restoration of esophageal integrity was 33 days (7–120 days). There were 22 successes (59%); 2 failures were secondary to undrained abscess. Only 2 failures occurred in the last 15 patients (88% success). Strictures did not develop in any patients. Serious complications occurred in 3 patients (stent erosion, leak enlargement, fatal gastroaortic fistula).
Esophageal stents can potentially play an integral role in the management of anastomotic leaks and perforations. Success depends on appropriate procedures for source control and surgeon experience.
Introduction: Esophageal Stents for Anastomotic Leaks and Perforations
2011, Seminars in Thoracic and Cardiovascular Surgery

View all citing articles on Scopus

^☆: Presented at the Twenty-ninth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 25–27, 1993.

View full text

Original articleTranshiatal esophagectomy for carcinoma of the esophagus☆

Abstract

J Thorac Cardiovasc Surg

Ann Thorac Surg

Ann Thorac Surg

Ann Thorac Surg

Ann Thorac Surg

Ann Thorac Surg

J Thorac Cardiovasc Surg

J Thorac Cardiovasc Surg

Ann Thorac Surg

Am J Surg

Ann Thorac Surg

J Thorac Cardiovasc Surg

Ann Thorac Surg

Am J Surg

Original article
Transhiatal esophagectomy for carcinoma of the esophagus☆